메뉴 건너뛰기




Volumn 23, Issue 1, 2014, Pages 9-17

Use of QT-prolonging medications in US emergency departments, 1995-2009

Author keywords

Drug induced QT prolongation; Emergency department; Pharmacoepidemiology; QT prolonging drug prescribing patterns; Torsade de Pointes

Indexed keywords

ANTIARRHYTHMIC AGENT; AZITHROMYCIN; COTRIMOXAZOLE; DIPHENHYDRAMINE; FAMOTIDINE; ONDANSETRON;

EID: 84891635544     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3455     Document Type: Article
Times cited : (21)

References (49)
  • 1
    • 0035293881 scopus 로고    scopus 로고
    • Risk assessment for antimicrobial agent-induced QTc interval prolongation and torsades de pointes
    • Owens RC, Jr. Risk assessment for antimicrobial agent-induced QTc interval prolongation and torsades de pointes. Pharmacotherapy 2001; 21(3): 301-319.
    • (2001) Pharmacotherapy , vol.21 , Issue.3 , pp. 301-319
    • Owens Jr., R.C.1
  • 2
    • 0021151427 scopus 로고
    • Long QT: good, bad or indifferent?
    • Surawicz B, Knoebel SB. Long QT: good, bad or indifferent?. J Am Coll Cardiol 1984; 4(2): 398-413.
    • (1984) J Am Coll Cardiol , vol.4 , Issue.2 , pp. 398-413
    • Surawicz, B.1    Knoebel, S.B.2
  • 3
    • 1442306232 scopus 로고    scopus 로고
    • Drug-induced prolongation of the QT interval
    • Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med 2004; 350(10): 1013-1022.
    • (2004) N Engl J Med , vol.350 , Issue.10 , pp. 1013-1022
    • Roden, D.M.1
  • 4
    • 0035150202 scopus 로고    scopus 로고
    • Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death
    • Glassman AH, Bigger JT, Jr. Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death. Am J Psychiatry 2001; 158(11): 1774-1782.
    • (2001) Am J Psychiatry , vol.158 , Issue.11 , pp. 1774-1782
    • Glassman, A.H.1    Bigger Jr., J.T.2
  • 5
    • 34249330240 scopus 로고    scopus 로고
    • Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes
    • Gupta A, Lawrence AT, Krishnan K, Kavinsky CJ, Trohman RG. Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes. Am Heart J 2007; 153(6): 891-899.
    • (2007) Am Heart J , vol.153 , Issue.6 , pp. 891-899
    • Gupta, A.1    Lawrence, A.T.2    Krishnan, K.3    Kavinsky, C.J.4    Trohman, R.G.5
  • 6
    • 0034074402 scopus 로고    scopus 로고
    • QT-interval prolongation by non-cardiac drugs: lessons to be learned from recent experience
    • De Ponti F, Poluzzi E, Montanaro N. QT-interval prolongation by non-cardiac drugs: lessons to be learned from recent experience. Eur J Clin Pharmacol 2000; 56(1): 1-18.
    • (2000) Eur J Clin Pharmacol , vol.56 , Issue.1 , pp. 1-18
    • De Ponti, F.1    Poluzzi, E.2    Montanaro, N.3
  • 8
    • 84891631323 scopus 로고    scopus 로고
    • FDA. FDA Drug Safety Communication: abnormal heart rhythms may be associated with use of Zofran (ondansetron).
    • FDA. FDA Drug Safety Communication: abnormal heart rhythms may be associated with use of Zofran (ondansetron). 2011; http://www.fda.gov/Drugs/DrugSafety/ucm271913.htm.
    • (2011)
  • 9
    • 84891624180 scopus 로고    scopus 로고
    • FDA. FDA Drug Safety Communication: abnormal heart rhythms associated with high doses of Celexa (citalopram hydrobromide).
    • FDA. FDA Drug Safety Communication: abnormal heart rhythms associated with high doses of Celexa (citalopram hydrobromide). 2011; http://www.fda.gov/Drugs/DrugSafety/ucm269086.htm.
    • (2011)
  • 10
    • 84891628509 scopus 로고    scopus 로고
    • FDA. FDA Drug Safety Communication: revised recommendations for Celexa (citalopram hydrobromide) related to a potential risk of abnormal heart rhythms with high doses.
    • FDA. FDA Drug Safety Communication: revised recommendations for Celexa (citalopram hydrobromide) related to a potential risk of abnormal heart rhythms with high doses. 2012; http://www.fda.gov/Drugs/DrugSafety/ucm297391.htm.
    • (2012)
  • 11
    • 0025935591 scopus 로고
    • The long QT syndrome. Prospective longitudinal study of 328 families
    • Moss AJ, Schwartz PJ, Crampton RS, et al. The long QT syndrome. Prospective longitudinal study of 328 families. Circulation 1991; 84(3): 1136-1144.
    • (1991) Circulation , vol.84 , Issue.3 , pp. 1136-1144
    • Moss, A.J.1    Schwartz, P.J.2    Crampton, R.S.3
  • 12
    • 2142660225 scopus 로고    scopus 로고
    • QT prolongation and fatal arrhythmias: a review of clinical implications and effects of drugs
    • Cubeddu LX. QT prolongation and fatal arrhythmias: a review of clinical implications and effects of drugs. Am J Ther 2003; 10(6): 452-457.
    • (2003) Am J Ther , vol.10 , Issue.6 , pp. 452-457
    • Cubeddu, L.X.1
  • 13
    • 0028606736 scopus 로고
    • Drug-induced torsade de pointes. Incidence, management and prevention
    • Faber TS, Zehender M, Just H. Drug-induced torsade de pointes. Incidence, management and prevention. Drug Saf 1994; 11(6): 463-476.
    • (1994) Drug Saf , vol.11 , Issue.6 , pp. 463-476
    • Faber, T.S.1    Zehender, M.2    Just, H.3
  • 14
    • 26444560585 scopus 로고    scopus 로고
    • Non-cardiac QTc-prolonging drugs and the risk of sudden cardiac death
    • Straus SM, Sturkenboom MC, Bleumink GS, et al. Non-cardiac QTc-prolonging drugs and the risk of sudden cardiac death. Eur Heart J 2005; 26(19): 2007-2012.
    • (2005) Eur Heart J , vol.26 , Issue.19 , pp. 2007-2012
    • Straus, S.M.1    Sturkenboom, M.C.2    Bleumink, G.S.3
  • 16
    • 34547603505 scopus 로고    scopus 로고
    • QT interval prolongation and torsades de pointes due to a coadministration of ciprofloxacin and azimilide in a patient with implantable cardioverter-defibrillator
    • Kazmierczak J, Peregud-Pogorzelska M, Rzeuski R. QT interval prolongation and torsades de pointes due to a coadministration of ciprofloxacin and azimilide in a patient with implantable cardioverter-defibrillator. Pacing Clin Electrophysiol 2007; 30(8): 1043-1046.
    • (2007) Pacing Clin Electrophysiol , vol.30 , Issue.8 , pp. 1043-1046
    • Kazmierczak, J.1    Peregud-Pogorzelska, M.2    Rzeuski, R.3
  • 17
    • 66349110617 scopus 로고    scopus 로고
    • Ciprofloxacin induced acquired long QT syndrome in a patient under class III antiarrhythmic therapy
    • Keivanidou A, Arnaoutoglou C, Krommydas A, et al. Ciprofloxacin induced acquired long QT syndrome in a patient under class III antiarrhythmic therapy. Cardiol J 2009; 16(2): 172-174.
    • (2009) Cardiol J , vol.16 , Issue.2 , pp. 172-174
    • Keivanidou, A.1    Arnaoutoglou, C.2    Krommydas, A.3
  • 18
    • 33748751081 scopus 로고    scopus 로고
    • Drug-induced QT interval prolongation after ciprofloxacin administration in a patient receiving olanzapine
    • Letsas KP, Sideris A, Kounas SP, Efremidis M, Korantzopoulos P, Kardaras F. Drug-induced QT interval prolongation after ciprofloxacin administration in a patient receiving olanzapine. Int J Cardiol 2006; 109(2): 273-274.
    • (2006) Int J Cardiol , vol.109 , Issue.2 , pp. 273-274
    • Letsas, K.P.1    Sideris, A.2    Kounas, S.P.3    Efremidis, M.4    Korantzopoulos, P.5    Kardaras, F.6
  • 19
    • 18844388158 scopus 로고    scopus 로고
    • QT interval prolongation and torsades de pointes due to a coadministration of metronidazole and amiodarone
    • Kounas SP, Letsas KP, Sideris A, Efraimidis M, Kardaras F. QT interval prolongation and torsades de pointes due to a coadministration of metronidazole and amiodarone. Pacing Clin Electrophysiol 2005; 28(5): 472-473.
    • (2005) Pacing Clin Electrophysiol , vol.28 , Issue.5 , pp. 472-473
    • Kounas, S.P.1    Letsas, K.P.2    Sideris, A.3    Efraimidis, M.4    Kardaras, F.5
  • 20
    • 84856995147 scopus 로고    scopus 로고
    • Pharmacokinetic interaction between domperidone and ketoconazole leads to QT prolongation in healthy volunteers: a randomized, placebo-controlled, double-blind, crossover study
    • Mar
    • Boyce MJ, Baisley KJ, Warrington SJ. Pharmacokinetic interaction between domperidone and ketoconazole leads to QT prolongation in healthy volunteers: a randomized, placebo-controlled, double-blind, crossover study. Br J Clin Pharmacol 2012 Mar; 73(3): 411-241.
    • (2012) Br J Clin Pharmacol , vol.73 , Issue.3 , pp. 411-241
    • Boyce, M.J.1    Baisley, K.J.2    Warrington, S.J.3
  • 21
    • 77951859419 scopus 로고    scopus 로고
    • Case report: drug interaction between tacrolimus and amiodarone with QT prolongation
    • Burger CI, Clase CM, Gangji AS. Case report: drug interaction between tacrolimus and amiodarone with QT prolongation. Transplantation 2010; 89(9): 1166-1167.
    • (2010) Transplantation , vol.89 , Issue.9 , pp. 1166-1167
    • Burger, C.I.1    Clase, C.M.2    Gangji, A.S.3
  • 22
    • 48849117034 scopus 로고    scopus 로고
    • Droperidol and ondansetron-induced QT interval prolongation: a clinical drug interaction study
    • Charbit B, Alvarez JC, Dasque E, Abe E, Demolis JL, Funck-Brentano C. Droperidol and ondansetron-induced QT interval prolongation: a clinical drug interaction study. Anesthesiology 2008; 109(2): 206-212.
    • (2008) Anesthesiology , vol.109 , Issue.2 , pp. 206-212
    • Charbit, B.1    Alvarez, J.C.2    Dasque, E.3    Abe, E.4    Demolis, J.L.5    Funck-Brentano, C.6
  • 23
    • 79959806525 scopus 로고    scopus 로고
    • Tamoxifen/norfloxacin interaction leading to QT interval prolongation in a female patient with extracranial meningioma
    • Slovacek L, Priester P, Petera J, Slanska I, Kopecky J. Tamoxifen/norfloxacin interaction leading to QT interval prolongation in a female patient with extracranial meningioma. Bratisl Lek Listy 2011; 112(6): 353-354.
    • (2011) Bratisl Lek Listy , vol.112 , Issue.6 , pp. 353-354
    • Slovacek, L.1    Priester, P.2    Petera, J.3    Slanska, I.4    Kopecky, J.5
  • 24
    • 0031953555 scopus 로고    scopus 로고
    • Prolongation of the QT interval related to cisapride-diltiazem interaction
    • Thomas AR, Chan LN, Bauman JL, Olopade CO. Prolongation of the QT interval related to cisapride-diltiazem interaction. Pharmacotherapy 1998; 18(2): 381-385.
    • (1998) Pharmacotherapy , vol.18 , Issue.2 , pp. 381-385
    • Thomas, A.R.1    Chan, L.N.2    Bauman, J.L.3    Olopade, C.O.4
  • 26
    • 79960599857 scopus 로고    scopus 로고
    • The prevalence of polypharmacy in elderly attenders to an emergency department-a problem with a need for an effective solution
    • Banerjee A, Mbamalu D, Ebrahimi S, Khan AA, Chan TF. The prevalence of polypharmacy in elderly attenders to an emergency department-a problem with a need for an effective solution. Int J Emerg Med 2011; 4(1): 22-24.
    • (2011) Int J Emerg Med , vol.4 , Issue.1 , pp. 22-24
    • Banerjee, A.1    Mbamalu, D.2    Ebrahimi, S.3    Khan, A.A.4    Chan, T.F.5
  • 28
    • 84855336780 scopus 로고    scopus 로고
    • Prevalence of polypharmacy exposure among hospitalized children in the United States
    • Feudtner C, Dai D, Hexem KR, Luan X, Metjian TA. Prevalence of polypharmacy exposure among hospitalized children in the United States. Arch Pediatr Adolesc Med 2012; 166(1): 9-16.
    • (2012) Arch Pediatr Adolesc Med , vol.166 , Issue.1 , pp. 9-16
    • Feudtner, C.1    Dai, D.2    Hexem, K.R.3    Luan, X.4    Metjian, T.A.5
  • 29
    • 0035213015 scopus 로고    scopus 로고
    • Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department
    • Hohl CM, Dankoff J, Colacone A, Afilalo M. Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department. Ann Emerg Med 2001; 38(6): 666-671.
    • (2001) Ann Emerg Med , vol.38 , Issue.6 , pp. 666-671
    • Hohl, C.M.1    Dankoff, J.2    Colacone, A.3    Afilalo, M.4
  • 30
    • 0037116642 scopus 로고    scopus 로고
    • Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey
    • Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA 2002; 287(3): 337-344.
    • (2002) JAMA , vol.287 , Issue.3 , pp. 337-344
    • Kaufman, D.W.1    Kelly, J.P.2    Rosenberg, L.3    Anderson, T.E.4    Mitchell, A.A.5
  • 31
    • 67749114319 scopus 로고    scopus 로고
    • Medication use among children <12years of age in the United States: results from the Slone Survey
    • Vernacchio L, Kelly JP, Kaufman DW, Mitchell AA. Medication use among children <12years of age in the United States: results from the Slone Survey. Pediatrics 2009; 124(2): 446-454.
    • (2009) Pediatrics , vol.124 , Issue.2 , pp. 446-454
    • Vernacchio, L.1    Kelly, J.P.2    Kaufman, D.W.3    Mitchell, A.A.4
  • 32
    • 84891633325 scopus 로고    scopus 로고
    • National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey Reason for Visit Classification and Coding Manual (updated annually).
    • National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey Reason for Visit Classification and Coding Manual (updated annually). http://www.cdc.gov/nchs/ahcd.htm.
  • 33
    • 38449106799 scopus 로고    scopus 로고
    • Medication use leading to emergency department visits for adverse drug events in older adults
    • Budnitz DS, Shehab N, Kegler SR, Richards CL. Medication use leading to emergency department visits for adverse drug events in older adults. Ann Intern Med 2007; 147(11): 755-765.
    • (2007) Ann Intern Med , vol.147 , Issue.11 , pp. 755-765
    • Budnitz, D.S.1    Shehab, N.2    Kegler, S.R.3    Richards, C.L.4
  • 34
    • 0037317605 scopus 로고    scopus 로고
    • Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients
    • Curtis LH, Ostbye T, Sendersky V, et al. Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients. Am J Med 2003; 114(2): 135-141.
    • (2003) Am J Med , vol.114 , Issue.2 , pp. 135-141
    • Curtis, L.H.1    Ostbye, T.2    Sendersky, V.3
  • 36
    • 78049473361 scopus 로고    scopus 로고
    • How many patients need QT interval monitoring in critical care units? Preliminary report of the QT in Practice study
    • Pickham D, Helfenbein E, Shinn JA, Chan G, Funk M, Drew BJ. How many patients need QT interval monitoring in critical care units? Preliminary report of the QT in Practice study. J Electrocardiol 2010; 43(6): 572-576.
    • (2010) J Electrocardiol , vol.43 , Issue.6 , pp. 572-576
    • Pickham, D.1    Helfenbein, E.2    Shinn, J.A.3    Chan, G.4    Funk, M.5    Drew, B.J.6
  • 38
    • 2442575876 scopus 로고    scopus 로고
    • Case of polymorphic ventricular tachycardia in diphenhydramine poisoning
    • Joshi AK, Sljapic T, Borghei H, Kowey PR. Case of polymorphic ventricular tachycardia in diphenhydramine poisoning. J Cardiovasc Electrophysiol 2004; 15(5): 591-593.
    • (2004) J Cardiovasc Electrophysiol , vol.15 , Issue.5 , pp. 591-593
    • Joshi, A.K.1    Sljapic, T.2    Borghei, H.3    Kowey, P.R.4
  • 39
    • 77957957228 scopus 로고    scopus 로고
    • Diphenhydramine induced QT prolongation and torsade de pointes: an uncommon effect of a common drug
    • Husain Z, Hussain K, Nair R, Steinman R. Diphenhydramine induced QT prolongation and torsade de pointes: an uncommon effect of a common drug. Cardiol J 2010; 17(5): 509-511.
    • (2010) Cardiol J , vol.17 , Issue.5 , pp. 509-511
    • Husain, Z.1    Hussain, K.2    Nair, R.3    Steinman, R.4
  • 40
    • 14644415585 scopus 로고    scopus 로고
    • Prolonged QT interval with markedly abnormal ventricular repolarization in diphenhydramine overdose
    • Sype JW, Khan IA. Prolonged QT interval with markedly abnormal ventricular repolarization in diphenhydramine overdose. Int J Cardiol 2005; 99(2): 333-335.
    • (2005) Int J Cardiol , vol.99 , Issue.2 , pp. 333-335
    • Sype, J.W.1    Khan, I.A.2
  • 42
    • 84891633907 scopus 로고    scopus 로고
    • FDA. Ondansetron Label and Approval History (IV).
    • FDA. Ondansetron Label and Approval History (IV). 2011; http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020007s042, 020403s020lbl.pdf.
    • (2011)
  • 43
    • 84891625286 scopus 로고    scopus 로고
    • FDA. Ondansetron Label and Approval History (oral). ;
    • FDA. Ondansetron Label and Approval History (oral). 2011; http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020103s030, 020605s014, 020781s014lbl.pdf.
    • (2011)
  • 44
    • 84855287376 scopus 로고    scopus 로고
    • Effect of intravenous ondansetron on QT interval prolongation in patients with cardiovascular disease and additional risk factors for torsades: a prospective, observational study
    • Hafermann MJ, Namdar R, Seibold GE, Page RL, 2nd. Effect of intravenous ondansetron on QT interval prolongation in patients with cardiovascular disease and additional risk factors for torsades: a prospective, observational study. Drug Healthc Patient Saf. 2011; 3: 53-58.
    • (2011) Drug Healthc Patient Saf. , vol.3 , pp. 53-58
    • Hafermann, M.J.1    Namdar, R.2    Seibold, G.E.3    Page, R.L.4
  • 45
    • 84859344815 scopus 로고    scopus 로고
    • Clinical and genetic determinants of torsade de pointes risk
    • Sauer AJ, Newton-Cheh C. Clinical and genetic determinants of torsade de pointes risk. Circulation 2012; 125(13): 1684-1694.
    • (2012) Circulation , vol.125 , Issue.13 , pp. 1684-1694
    • Sauer, A.J.1    Newton-Cheh, C.2
  • 46
    • 22544483871 scopus 로고    scopus 로고
    • The long QT syndrome: therapeutic implications of a genetic diagnosis
    • Shimizu W. The long QT syndrome: therapeutic implications of a genetic diagnosis. Cardiovasc Res 2005; 67(3): 347-356.
    • (2005) Cardiovasc Res , vol.67 , Issue.3 , pp. 347-356
    • Shimizu, W.1
  • 47
    • 56249099670 scopus 로고    scopus 로고
    • Epidemiology of sudden cardiac death: clinical and research implications
    • Chugh SS, Reinier K, Teodorescu C, et al. Epidemiology of sudden cardiac death: clinical and research implications. Prog Cardiovasc Dis 2008; 51(3): 213-228.
    • (2008) Prog Cardiovasc Dis , vol.51 , Issue.3 , pp. 213-228
    • Chugh, S.S.1    Reinier, K.2    Teodorescu, C.3
  • 48
    • 84865469365 scopus 로고    scopus 로고
    • How reliable are patient-completed medication reconciliation forms compared with pharmacy lists?
    • Sep;
    • Meyer C, Stern M, Woolley W, Jeanmonod R, Jeanmonod D. How reliable are patient-completed medication reconciliation forms compared with pharmacy lists?. Am J Emerg Med 2012 Sep; 30(7): 1048-1054.
    • (2012) Am J Emerg Med , vol.30 , Issue.7 , pp. 1048-1054
    • Meyer, C.1    Stern, M.2    Woolley, W.3    Jeanmonod, R.4    Jeanmonod, D.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.